Xiaping He
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics 11
- Breast Cancer Treatment Studies 10
- Oncology top 0.5%
- Cancer Cells and Metastasis 7
- Cancer-related Molecular Pathways 7
- HER2/EGFR in Cancer Research 4
- Molecular Biology top 1%
- Molecular Biology Techniques and Applications 8
- Gene expression and cancer classification 7
- RNA modifications and cancer 5
- Genetics top 2%
- Co-authors
- Charles M. PerouJoel S. ParkerCheng FanJason I. HerschkowitzChad LivasyAleix PratZhiyuan HuOlga Karginova
- Journals
- Journal of Clinical Oncology (6 papers)Breast Cancer Research and Treatment (5 papers)Cancer Research (4 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Xiaping He
40 papers receiving 8.5k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Cancer Research 4.3k
- Oncology 4.1k
- Molecular Biology 4.8k
- Pulmonary and Respiratory Medicine 1.3k
- Genetics 925
Countries citing papers authored by Xiaping He
This map shows the geographic impact of Xiaping He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaping He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaping He more than expected).
Fields of papers citing papers by Xiaping He
This network shows the impact of papers produced by Xiaping He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaping He. The network helps show where Xiaping He may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaping He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 11 | |
| 2 | 2022 | 6 | |
| 3 | 2021 | 8 | |
| 4 | 2021 | 53 | |
| 5 | 2019 | 307 | |
| 6 | 2016 | 69 | |
| 7 | 2015 | 36 | |
| 8 | 2012 | 14 | |
| 9 | 2011 | 57 | |
| 10 | 2011 | 166 | |
| 11 | 2011 | 90 | |
| 12 | 2011 | 52 | |
| 13 | Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancerbreakdown → | 2010 | 1575 |
| 14 | 2009 | 139 | |
| 15 | Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypesbreakdown → | 2009 | 3093 |
| 16 | 2008 | 133 | |
| 17 | 2007 | 222 | |
| 18 | 2007 | 132 | |
| 19 | 2006 | 116 | |
| 20 | 2004 | 198 |
About Xiaping He
Xiaping He is a scholar working on Cancer Research, Oncology, Molecular Biology, Genetics and Pulmonary and Respiratory Medicine, having authored 47 papers that have together received 8.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (11 papers), Breast Cancer Treatment Studies (10 papers), Molecular Biology Techniques and Applications (8 papers), Cancer Cells and Metastasis (7 papers), Cancer-related Molecular Pathways (7 papers), Gene expression and cancer classification (7 papers), RNA modifications and cancer (5 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Cancer Research (4.3k citations), Oncology (4.1k citations), Molecular Biology (4.8k citations), Pulmonary and Respiratory Medicine (1.3k citations) and Genetics (925 citations). Xiaping He has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Charles M. Perou, Joel S. Parker, Cheng Fan, Jason I. Herschkowitz, Chad Livasy, Aleix Prat, Zhiyuan Hu, Olga Karginova, Philip S. Bernard and Maggie C.U. Cheang. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Cancer Research, Breast Cancer Research and BMC Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.